Endpoint Clinical: Christine Oliver, CEO
Endpoint Clinical, an interactive response technology (IRT) firm serving the life-science industry, has appointed Christine Oliver as CEO. Her responsibilities will include continuing to drive the company’s position in the marketplace.
Oliver brings more than 20 years of experience combining a passion for advancing clinical technology with an entrepreneurial mindset to drive change in getting therapies to patients faster. Before joining Endpoint in 2013, she served in a number of pharma/biotech industry roles, including a five-year tenure with Takeda Oncology.
